Restoration of miR‐299‐3p promotes efferocytosis and ameliorates atherosclerosis via repressing CD47 in mice

Atherosclerotic plaque formation is largely attributed to the impaired efferocytosis, which is known to be associated with the pathologic upregulation of cluster of differentiation 47 (CD47), a key antiphagocytic molecule. By gene expression omnibus (GEO) datasets analysis, we identified that four miRNAs are aberrantly downregulated in atherosclerosis, coronary artery disease, and obesity. Of them, hsa‐miR‐299‐3p (miR‐299‐3p) was predicted to target the 3′UTR of human CD47 mRNA by bioinformatics analysis. Further, we demonstrated that miR‐299‐3p negatively regulates CD47 expression by binding to the target sequence “CCCACAU” in the 3′UTR of CD47 mRNA through luciferase reporter assay and site‐directed mutagenesis. Additionally, we found that miR‐299‐3p was downregulated by ~32% in foam cells in response to oxidized low‐density lipoprotein (ox‐LDL) stimulation, thus upregulating CD47 and contributing to the impaired efferocytosis. Whereas, restoration of miR‐299‐3p reversed the ox‐LDL‐induced upregulation of CD47, thereby facilitating efferocytosis. In high‐fat diet (HFD) fed ApoE−/− mice, we discovered that miR‐299‐3p was downregulated thus leading to upregulation of CD47 in abdominal aorta. Conversely, miR‐299‐3p restoration potently suppressed HFD‐induced upregulation of CD47 and promoted phagocytosis of foam cells by macrophages in atherosclerotic plaques, thereby reducing necrotic core, increasing plaque stability, and mitigating atherosclerosis. Conclusively, we identify miR‐299‐3p as a negative regulator of CD47, and reveal a molecular mechanism whereby the ox‐LDL‐induced downregulation of miR‐299‐3p leads to the upregulation of CD47 in foam cells thus contributing to the impaired efferocytosis in atherosclerosis, and propose miR‐299‐3p can potentially serve as an inhibitor of CD47 to promote efferocytosis and ameliorate atherosclerosis. Schematic diagram shows the roles of miR‐299‐3p in restoring efferocytosis and ameliorating atherosclerosis via repressing CD47 in ApoE−/− mice. We identify miR‐299‐3p as a negative regulator of CD47, and reveal a molecular mechanism whereby the ox‐LDL‐induced downregulation of miR‐299‐3p leads to the upregulation of CD47 in foam cells thus contributing to the impaired efferocytosis in atherosclerosis, and propose miR‐299‐3p can potentially serve as an inhibitor of CD47 to promote efferocytosis and ameliorate atherosclerosis.